Detalhe da pesquisa
1.
Folate receptor targeted nanoparticles containing niraparib and doxorubicin as a potential candidate for the treatment of high grade serous ovarian cancer.
Sci Rep
; 13(1): 3226, 2023 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828860
2.
Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro.
Sci Rep
; 11(1): 11103, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34045581